Cambrian BioPharma Inc - 18 Feb 2021 Form 4/A - Amendment Insider Report for Sensei Biotherapeutics, Inc. (SNSE)

Role
10%+ Owner
Signature
Cambrian Biopharma, Inc. By: /s/ James Peyer
Issuer symbol
SNSE
Transactions as of
18 Feb 2021
Transactions value $
$14,852
Form type
4/A - Amendment
Filing time
21 Apr 2022, 16:17:48
Date Of Original Report
19 Feb 2021
Next filing
21 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNSE Common Stock Purchase $14.9K +752 +0.02% $19.75* 4.69M 18 Feb 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 is being amended to correct the number of shares purchased. The original Form 4 filed on February 19, 2021, overstated the number of shares purchased.
F2 These shares are held by Cambrian Biopharma, Inc., a Delaware corporation ("Cambrian"). The Chief Executive Officer of Cambrian, James Peyer, may direct the voting and disposition of the shares held by Cambrian, subject in certain instances to the approval of Cambrian's Board of Directors. Mr. Peyer disclaims beneficial ownership of such shares.